Genome Editing to Create Personalized Safe and Effective Medicines

Update: 2022-04-01

Description

Genome editing gives precise control of the type of genetic modification made to a cell. Hematopoietic stem cells have pharmacologic properties of durability and output that still remain untapped. Matthew Porteus and his group are using genome editing of hematopoietic stem cells to develop new classes of drugs to treat patients.

Comments

In Channel

Plant Engineering. Legal and Economic Aspects

2022-07-2501:39:50

Engineering our Ecosystems. Gene Drive and Local Drive

2022-07-1901:12:02

Human Engineering. Medical and Ethical Aspects and Prospects

2022-05-2301:35:57

Genome Editing to Create Personalized Safe and Effective Medicines

2022-04-0101:00:19

Safety and Efficacy of CRISPR/Cas9 based Gene edited Hematopoietic Stem and Progenitor Cells in Hemoglobinopathies

2021-04-2056:42

CRISPR/Cas - A New Tool or a Revolutionary Method?

2021-02-1101:30:48

00:00

Genome Editing to Create Personalized Safe and Effective Medicines

Referent: Prof. Matthew Porteus, Ph.D. (Stanford) | Moderation: Prof. Dr. Christoph Klein (LMU)

#box-pro-ellipsis-175963187808684{-webkit-line-clamp:2;}Genome Editing to Create Personalized Safe and Effective Medicines

Genome Editing to Create Personalized Safe and Effective Medicines

Referent: Prof. Matthew Porteus, Ph.D. (Stanford) | Moderation: Prof. Dr. Christoph Klein (LMU)

Genome Editing to Create Personalized Safe and Effective Medicines